Global Psychedelic Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Psychedelic Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Psychedelic Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Psychedelic Drugs market. Psychedelic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psychedelic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psychedelic Drugs market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psychedelic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psychedelic Drugs market. It may include historical data, market segmentation by Type (e.g., Psilocybin, LSD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psychedelic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psychedelic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psychedelic Drugs industry. This include advancements in Psychedelic Drugs technology, Psychedelic Drugs new entrants, Psychedelic Drugs new investment, and other innovations that are shaping the future of Psychedelic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psychedelic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Psychedelic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psychedelic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psychedelic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psychedelic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psychedelic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psychedelic Drugs market.
Market Segmentation:
Psychedelic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Psychedelic Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Psychedelic Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Psychedelic Drugs market. Psychedelic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psychedelic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psychedelic Drugs market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psychedelic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psychedelic Drugs market. It may include historical data, market segmentation by Type (e.g., Psilocybin, LSD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psychedelic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psychedelic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psychedelic Drugs industry. This include advancements in Psychedelic Drugs technology, Psychedelic Drugs new entrants, Psychedelic Drugs new investment, and other innovations that are shaping the future of Psychedelic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psychedelic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Psychedelic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psychedelic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psychedelic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psychedelic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psychedelic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psychedelic Drugs market.
Market Segmentation:
Psychedelic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Others
- Depressive Disorders
- Post-Traumatic Stress Disorders
- Substance Abuse Disorders
- Obsessive Compulsive Disorders
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- COMPASS Pathways PLC
- Pfizer
- Eli Lilly
- GlaxoSmithKline
- Cybin Inc
- Field Trip Health
- ATAI Life Sciences
- NUMINUS WELLNESS
- MindMed
- HAVN Life Sciences
- Seelos Therapeutics
- Jannsen
- Acadia Pharmaceuticals
- Intellipharmaceutics
- Revive Therapeutics
- Mydecine Innovations Group
- Red Light Holland
- Braxia Scientific
- Mind Cure Health
- Entheon Biomedical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychedelic Drugs Market Size 2019-2030
2.1.2 Psychedelic Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Psychedelic Drugs Segment by Type
2.2.1 Psilocybin
2.2.2 LSD
2.2.3 MDMA
2.2.4 DMT
2.2.5 Ketamine
2.2.6 Others
2.3 Psychedelic Drugs Market Size by Type
2.3.1 Psychedelic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Psychedelic Drugs Market Size Market Share by Type (2019-2024)
2.4 Psychedelic Drugs Segment by Application
2.4.1 Depressive Disorders
2.4.2 Post-Traumatic Stress Disorders
2.4.3 Substance Abuse Disorders
2.4.4 Obsessive Compulsive Disorders
2.4.5 Others
2.5 Psychedelic Drugs Market Size by Application
2.5.1 Psychedelic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Psychedelic Drugs Market Size Market Share by Application (2019-2024)
3 PSYCHEDELIC DRUGS MARKET SIZE BY PLAYER
3.1 Psychedelic Drugs Market Size Market Share by Players
3.1.1 Global Psychedelic Drugs Revenue by Players (2019-2024)
3.1.2 Global Psychedelic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Psychedelic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHEDELIC DRUGS BY REGIONS
4.1 Psychedelic Drugs Market Size by Regions (2019-2024)
4.2 Americas Psychedelic Drugs Market Size Growth (2019-2024)
4.3 APAC Psychedelic Drugs Market Size Growth (2019-2024)
4.4 Europe Psychedelic Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Psychedelic Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Psychedelic Drugs Market Size by Country (2019-2024)
5.2 Americas Psychedelic Drugs Market Size by Type (2019-2024)
5.3 Americas Psychedelic Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychedelic Drugs Market Size by Region (2019-2024)
6.2 APAC Psychedelic Drugs Market Size by Type (2019-2024)
6.3 APAC Psychedelic Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychedelic Drugs by Country (2019-2024)
7.2 Europe Psychedelic Drugs Market Size by Type (2019-2024)
7.3 Europe Psychedelic Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychedelic Drugs by Region (2019-2024)
8.2 Middle East & Africa Psychedelic Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Psychedelic Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHEDELIC DRUGS MARKET FORECAST
10.1 Global Psychedelic Drugs Forecast by Regions (2025-2030)
10.1.1 Global Psychedelic Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Psychedelic Drugs Forecast
10.1.3 APAC Psychedelic Drugs Forecast
10.1.4 Europe Psychedelic Drugs Forecast
10.1.5 Middle East & Africa Psychedelic Drugs Forecast
10.2 Americas Psychedelic Drugs Forecast by Country (2025-2030)
10.2.1 United States Psychedelic Drugs Market Forecast
10.2.2 Canada Psychedelic Drugs Market Forecast
10.2.3 Mexico Psychedelic Drugs Market Forecast
10.2.4 Brazil Psychedelic Drugs Market Forecast
10.3 APAC Psychedelic Drugs Forecast by Region (2025-2030)
10.3.1 China Psychedelic Drugs Market Forecast
10.3.2 Japan Psychedelic Drugs Market Forecast
10.3.3 Korea Psychedelic Drugs Market Forecast
10.3.4 Southeast Asia Psychedelic Drugs Market Forecast
10.3.5 India Psychedelic Drugs Market Forecast
10.3.6 Australia Psychedelic Drugs Market Forecast
10.4 Europe Psychedelic Drugs Forecast by Country (2025-2030)
10.4.1 Germany Psychedelic Drugs Market Forecast
10.4.2 France Psychedelic Drugs Market Forecast
10.4.3 UK Psychedelic Drugs Market Forecast
10.4.4 Italy Psychedelic Drugs Market Forecast
10.4.5 Russia Psychedelic Drugs Market Forecast
10.5 Middle East & Africa Psychedelic Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Psychedelic Drugs Market Forecast
10.5.2 South Africa Psychedelic Drugs Market Forecast
10.5.3 Israel Psychedelic Drugs Market Forecast
10.5.4 Turkey Psychedelic Drugs Market Forecast
10.5.5 GCC Countries Psychedelic Drugs Market Forecast
10.6 Global Psychedelic Drugs Forecast by Type (2025-2030)
10.7 Global Psychedelic Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Information
11.1.2 COMPASS Pathways PLC Psychedelic Drugs Product Offered
11.1.3 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 COMPASS Pathways PLC Main Business Overview
11.1.5 COMPASS Pathways PLC Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Psychedelic Drugs Product Offered
11.2.3 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Psychedelic Drugs Product Offered
11.3.3 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Psychedelic Drugs Product Offered
11.4.3 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Cybin Inc
11.5.1 Cybin Inc Company Information
11.5.2 Cybin Inc Psychedelic Drugs Product Offered
11.5.3 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cybin Inc Main Business Overview
11.5.5 Cybin Inc Latest Developments
11.6 Field Trip Health
11.6.1 Field Trip Health Company Information
11.6.2 Field Trip Health Psychedelic Drugs Product Offered
11.6.3 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Field Trip Health Main Business Overview
11.6.5 Field Trip Health Latest Developments
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Information
11.7.2 ATAI Life Sciences Psychedelic Drugs Product Offered
11.7.3 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ATAI Life Sciences Main Business Overview
11.7.5 ATAI Life Sciences Latest Developments
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Information
11.8.2 NUMINUS WELLNESS Psychedelic Drugs Product Offered
11.8.3 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NUMINUS WELLNESS Main Business Overview
11.8.5 NUMINUS WELLNESS Latest Developments
11.9 MindMed
11.9.1 MindMed Company Information
11.9.2 MindMed Psychedelic Drugs Product Offered
11.9.3 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MindMed Main Business Overview
11.9.5 MindMed Latest Developments
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Information
11.10.2 HAVN Life Sciences Psychedelic Drugs Product Offered
11.10.3 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 HAVN Life Sciences Main Business Overview
11.10.5 HAVN Life Sciences Latest Developments
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Information
11.11.2 Seelos Therapeutics Psychedelic Drugs Product Offered
11.11.3 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Seelos Therapeutics Main Business Overview
11.11.5 Seelos Therapeutics Latest Developments
11.12 Jannsen
11.12.1 Jannsen Company Information
11.12.2 Jannsen Psychedelic Drugs Product Offered
11.12.3 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Jannsen Main Business Overview
11.12.5 Jannsen Latest Developments
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Information
11.13.2 Acadia Pharmaceuticals Psychedelic Drugs Product Offered
11.13.3 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acadia Pharmaceuticals Main Business Overview
11.13.5 Acadia Pharmaceuticals Latest Developments
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Information
11.14.2 Intellipharmaceutics Psychedelic Drugs Product Offered
11.14.3 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Intellipharmaceutics Main Business Overview
11.14.5 Intellipharmaceutics Latest Developments
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Information
11.15.2 Revive Therapeutics Psychedelic Drugs Product Offered
11.15.3 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Revive Therapeutics Main Business Overview
11.15.5 Revive Therapeutics Latest Developments
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Information
11.16.2 Mydecine Innovations Group Psychedelic Drugs Product Offered
11.16.3 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Mydecine Innovations Group Main Business Overview
11.16.5 Mydecine Innovations Group Latest Developments
11.17 Red Light Holland
11.17.1 Red Light Holland Company Information
11.17.2 Red Light Holland Psychedelic Drugs Product Offered
11.17.3 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Red Light Holland Main Business Overview
11.17.5 Red Light Holland Latest Developments
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Information
11.18.2 Braxia Scientific Psychedelic Drugs Product Offered
11.18.3 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Braxia Scientific Main Business Overview
11.18.5 Braxia Scientific Latest Developments
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Information
11.19.2 Mind Cure Health Psychedelic Drugs Product Offered
11.19.3 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Mind Cure Health Main Business Overview
11.19.5 Mind Cure Health Latest Developments
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Information
11.20.2 Entheon Biomedical Psychedelic Drugs Product Offered
11.20.3 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Entheon Biomedical Main Business Overview
11.20.5 Entheon Biomedical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychedelic Drugs Market Size 2019-2030
2.1.2 Psychedelic Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Psychedelic Drugs Segment by Type
2.2.1 Psilocybin
2.2.2 LSD
2.2.3 MDMA
2.2.4 DMT
2.2.5 Ketamine
2.2.6 Others
2.3 Psychedelic Drugs Market Size by Type
2.3.1 Psychedelic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Psychedelic Drugs Market Size Market Share by Type (2019-2024)
2.4 Psychedelic Drugs Segment by Application
2.4.1 Depressive Disorders
2.4.2 Post-Traumatic Stress Disorders
2.4.3 Substance Abuse Disorders
2.4.4 Obsessive Compulsive Disorders
2.4.5 Others
2.5 Psychedelic Drugs Market Size by Application
2.5.1 Psychedelic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Psychedelic Drugs Market Size Market Share by Application (2019-2024)
3 PSYCHEDELIC DRUGS MARKET SIZE BY PLAYER
3.1 Psychedelic Drugs Market Size Market Share by Players
3.1.1 Global Psychedelic Drugs Revenue by Players (2019-2024)
3.1.2 Global Psychedelic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Psychedelic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHEDELIC DRUGS BY REGIONS
4.1 Psychedelic Drugs Market Size by Regions (2019-2024)
4.2 Americas Psychedelic Drugs Market Size Growth (2019-2024)
4.3 APAC Psychedelic Drugs Market Size Growth (2019-2024)
4.4 Europe Psychedelic Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Psychedelic Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Psychedelic Drugs Market Size by Country (2019-2024)
5.2 Americas Psychedelic Drugs Market Size by Type (2019-2024)
5.3 Americas Psychedelic Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychedelic Drugs Market Size by Region (2019-2024)
6.2 APAC Psychedelic Drugs Market Size by Type (2019-2024)
6.3 APAC Psychedelic Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychedelic Drugs by Country (2019-2024)
7.2 Europe Psychedelic Drugs Market Size by Type (2019-2024)
7.3 Europe Psychedelic Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychedelic Drugs by Region (2019-2024)
8.2 Middle East & Africa Psychedelic Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Psychedelic Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHEDELIC DRUGS MARKET FORECAST
10.1 Global Psychedelic Drugs Forecast by Regions (2025-2030)
10.1.1 Global Psychedelic Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Psychedelic Drugs Forecast
10.1.3 APAC Psychedelic Drugs Forecast
10.1.4 Europe Psychedelic Drugs Forecast
10.1.5 Middle East & Africa Psychedelic Drugs Forecast
10.2 Americas Psychedelic Drugs Forecast by Country (2025-2030)
10.2.1 United States Psychedelic Drugs Market Forecast
10.2.2 Canada Psychedelic Drugs Market Forecast
10.2.3 Mexico Psychedelic Drugs Market Forecast
10.2.4 Brazil Psychedelic Drugs Market Forecast
10.3 APAC Psychedelic Drugs Forecast by Region (2025-2030)
10.3.1 China Psychedelic Drugs Market Forecast
10.3.2 Japan Psychedelic Drugs Market Forecast
10.3.3 Korea Psychedelic Drugs Market Forecast
10.3.4 Southeast Asia Psychedelic Drugs Market Forecast
10.3.5 India Psychedelic Drugs Market Forecast
10.3.6 Australia Psychedelic Drugs Market Forecast
10.4 Europe Psychedelic Drugs Forecast by Country (2025-2030)
10.4.1 Germany Psychedelic Drugs Market Forecast
10.4.2 France Psychedelic Drugs Market Forecast
10.4.3 UK Psychedelic Drugs Market Forecast
10.4.4 Italy Psychedelic Drugs Market Forecast
10.4.5 Russia Psychedelic Drugs Market Forecast
10.5 Middle East & Africa Psychedelic Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Psychedelic Drugs Market Forecast
10.5.2 South Africa Psychedelic Drugs Market Forecast
10.5.3 Israel Psychedelic Drugs Market Forecast
10.5.4 Turkey Psychedelic Drugs Market Forecast
10.5.5 GCC Countries Psychedelic Drugs Market Forecast
10.6 Global Psychedelic Drugs Forecast by Type (2025-2030)
10.7 Global Psychedelic Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Information
11.1.2 COMPASS Pathways PLC Psychedelic Drugs Product Offered
11.1.3 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 COMPASS Pathways PLC Main Business Overview
11.1.5 COMPASS Pathways PLC Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Psychedelic Drugs Product Offered
11.2.3 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Psychedelic Drugs Product Offered
11.3.3 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Psychedelic Drugs Product Offered
11.4.3 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Cybin Inc
11.5.1 Cybin Inc Company Information
11.5.2 Cybin Inc Psychedelic Drugs Product Offered
11.5.3 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cybin Inc Main Business Overview
11.5.5 Cybin Inc Latest Developments
11.6 Field Trip Health
11.6.1 Field Trip Health Company Information
11.6.2 Field Trip Health Psychedelic Drugs Product Offered
11.6.3 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Field Trip Health Main Business Overview
11.6.5 Field Trip Health Latest Developments
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Information
11.7.2 ATAI Life Sciences Psychedelic Drugs Product Offered
11.7.3 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ATAI Life Sciences Main Business Overview
11.7.5 ATAI Life Sciences Latest Developments
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Information
11.8.2 NUMINUS WELLNESS Psychedelic Drugs Product Offered
11.8.3 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NUMINUS WELLNESS Main Business Overview
11.8.5 NUMINUS WELLNESS Latest Developments
11.9 MindMed
11.9.1 MindMed Company Information
11.9.2 MindMed Psychedelic Drugs Product Offered
11.9.3 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MindMed Main Business Overview
11.9.5 MindMed Latest Developments
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Information
11.10.2 HAVN Life Sciences Psychedelic Drugs Product Offered
11.10.3 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 HAVN Life Sciences Main Business Overview
11.10.5 HAVN Life Sciences Latest Developments
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Information
11.11.2 Seelos Therapeutics Psychedelic Drugs Product Offered
11.11.3 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Seelos Therapeutics Main Business Overview
11.11.5 Seelos Therapeutics Latest Developments
11.12 Jannsen
11.12.1 Jannsen Company Information
11.12.2 Jannsen Psychedelic Drugs Product Offered
11.12.3 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Jannsen Main Business Overview
11.12.5 Jannsen Latest Developments
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Information
11.13.2 Acadia Pharmaceuticals Psychedelic Drugs Product Offered
11.13.3 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acadia Pharmaceuticals Main Business Overview
11.13.5 Acadia Pharmaceuticals Latest Developments
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Information
11.14.2 Intellipharmaceutics Psychedelic Drugs Product Offered
11.14.3 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Intellipharmaceutics Main Business Overview
11.14.5 Intellipharmaceutics Latest Developments
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Information
11.15.2 Revive Therapeutics Psychedelic Drugs Product Offered
11.15.3 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Revive Therapeutics Main Business Overview
11.15.5 Revive Therapeutics Latest Developments
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Information
11.16.2 Mydecine Innovations Group Psychedelic Drugs Product Offered
11.16.3 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Mydecine Innovations Group Main Business Overview
11.16.5 Mydecine Innovations Group Latest Developments
11.17 Red Light Holland
11.17.1 Red Light Holland Company Information
11.17.2 Red Light Holland Psychedelic Drugs Product Offered
11.17.3 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Red Light Holland Main Business Overview
11.17.5 Red Light Holland Latest Developments
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Information
11.18.2 Braxia Scientific Psychedelic Drugs Product Offered
11.18.3 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Braxia Scientific Main Business Overview
11.18.5 Braxia Scientific Latest Developments
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Information
11.19.2 Mind Cure Health Psychedelic Drugs Product Offered
11.19.3 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Mind Cure Health Main Business Overview
11.19.5 Mind Cure Health Latest Developments
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Information
11.20.2 Entheon Biomedical Psychedelic Drugs Product Offered
11.20.3 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Entheon Biomedical Main Business Overview
11.20.5 Entheon Biomedical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psychedelic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Psilocybin
Table 3. Major Players of LSD
Table 4. Major Players of MDMA
Table 5. Major Players of DMT
Table 6. Major Players of Ketamine
Table 7. Major Players of Others
Table 8. Psychedelic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 11. Psychedelic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 14. Global Psychedelic Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Psychedelic Drugs Revenue Market Share by Player (2019-2024)
Table 16. Psychedelic Drugs Key Players Head office and Products Offered
Table 17. Psychedelic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Psychedelic Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Psychedelic Drugs Market Size Market Share by Regions (2019-2024)
Table 22. Global Psychedelic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Psychedelic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Psychedelic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Psychedelic Drugs Market Size Market Share by Country (2019-2024)
Table 26. Americas Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 28. Americas Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 30. APAC Psychedelic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Psychedelic Drugs Market Size Market Share by Region (2019-2024)
Table 32. APAC Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 34. APAC Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 36. Europe Psychedelic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Psychedelic Drugs Market Size Market Share by Country (2019-2024)
Table 38. Europe Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 40. Europe Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Psychedelic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Psychedelic Drugs
Table 49. Key Market Challenges & Risks of Psychedelic Drugs
Table 50. Key Industry Trends of Psychedelic Drugs
Table 51. Global Psychedelic Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Psychedelic Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Psychedelic Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Psychedelic Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. COMPASS Pathways PLC Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 56. COMPASS Pathways PLC Psychedelic Drugs Product Offered
Table 57. COMPASS Pathways PLC Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. COMPASS Pathways PLC Main Business
Table 59. COMPASS Pathways PLC Latest Developments
Table 60. Pfizer Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 61. Pfizer Psychedelic Drugs Product Offered
Table 62. Pfizer Main Business
Table 63. Pfizer Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Pfizer Latest Developments
Table 65. Eli Lilly Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 66. Eli Lilly Psychedelic Drugs Product Offered
Table 67. Eli Lilly Main Business
Table 68. Eli Lilly Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Eli Lilly Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 71. GlaxoSmithKline Psychedelic Drugs Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Cybin Inc Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 76. Cybin Inc Psychedelic Drugs Product Offered
Table 77. Cybin Inc Main Business
Table 78. Cybin Inc Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Cybin Inc Latest Developments
Table 80. Field Trip Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 81. Field Trip Health Psychedelic Drugs Product Offered
Table 82. Field Trip Health Main Business
Table 83. Field Trip Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Field Trip Health Latest Developments
Table 85. ATAI Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 86. ATAI Life Sciences Psychedelic Drugs Product Offered
Table 87. ATAI Life Sciences Main Business
Table 88. ATAI Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. ATAI Life Sciences Latest Developments
Table 90. NUMINUS WELLNESS Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 91. NUMINUS WELLNESS Psychedelic Drugs Product Offered
Table 92. NUMINUS WELLNESS Main Business
Table 93. NUMINUS WELLNESS Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. NUMINUS WELLNESS Latest Developments
Table 95. MindMed Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 96. MindMed Psychedelic Drugs Product Offered
Table 97. MindMed Main Business
Table 98. MindMed Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. MindMed Latest Developments
Table 100. HAVN Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 101. HAVN Life Sciences Psychedelic Drugs Product Offered
Table 102. HAVN Life Sciences Main Business
Table 103. HAVN Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. HAVN Life Sciences Latest Developments
Table 105. Seelos Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 106. Seelos Therapeutics Psychedelic Drugs Product Offered
Table 107. Seelos Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Seelos Therapeutics Main Business
Table 109. Seelos Therapeutics Latest Developments
Table 110. Jannsen Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 111. Jannsen Psychedelic Drugs Product Offered
Table 112. Jannsen Main Business
Table 113. Jannsen Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Jannsen Latest Developments
Table 115. Acadia Pharmaceuticals Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 116. Acadia Pharmaceuticals Psychedelic Drugs Product Offered
Table 117. Acadia Pharmaceuticals Main Business
Table 118. Acadia Pharmaceuticals Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Acadia Pharmaceuticals Latest Developments
Table 120. Intellipharmaceutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 121. Intellipharmaceutics Psychedelic Drugs Product Offered
Table 122. Intellipharmaceutics Main Business
Table 123. Intellipharmaceutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Intellipharmaceutics Latest Developments
Table 125. Revive Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 126. Revive Therapeutics Psychedelic Drugs Product Offered
Table 127. Revive Therapeutics Main Business
Table 128. Revive Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Revive Therapeutics Latest Developments
Table 130. Mydecine Innovations Group Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 131. Mydecine Innovations Group Psychedelic Drugs Product Offered
Table 132. Mydecine Innovations Group Main Business
Table 133. Mydecine Innovations Group Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Mydecine Innovations Group Latest Developments
Table 135. Red Light Holland Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 136. Red Light Holland Psychedelic Drugs Product Offered
Table 137. Red Light Holland Main Business
Table 138. Red Light Holland Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Red Light Holland Latest Developments
Table 140. Braxia Scientific Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 141. Braxia Scientific Psychedelic Drugs Product Offered
Table 142. Braxia Scientific Main Business
Table 143. Braxia Scientific Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Braxia Scientific Latest Developments
Table 145. Mind Cure Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 146. Mind Cure Health Psychedelic Drugs Product Offered
Table 147. Mind Cure Health Main Business
Table 148. Mind Cure Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Mind Cure Health Latest Developments
Table 150. Entheon Biomedical Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 151. Entheon Biomedical Psychedelic Drugs Product Offered
Table 152. Entheon Biomedical Main Business
Table 153. Entheon Biomedical Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Entheon Biomedical Latest Developments
Table 1. Psychedelic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Psilocybin
Table 3. Major Players of LSD
Table 4. Major Players of MDMA
Table 5. Major Players of DMT
Table 6. Major Players of Ketamine
Table 7. Major Players of Others
Table 8. Psychedelic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 11. Psychedelic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 14. Global Psychedelic Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Psychedelic Drugs Revenue Market Share by Player (2019-2024)
Table 16. Psychedelic Drugs Key Players Head office and Products Offered
Table 17. Psychedelic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Psychedelic Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Psychedelic Drugs Market Size Market Share by Regions (2019-2024)
Table 22. Global Psychedelic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Psychedelic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Psychedelic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Psychedelic Drugs Market Size Market Share by Country (2019-2024)
Table 26. Americas Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 28. Americas Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 30. APAC Psychedelic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Psychedelic Drugs Market Size Market Share by Region (2019-2024)
Table 32. APAC Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 34. APAC Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 36. Europe Psychedelic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Psychedelic Drugs Market Size Market Share by Country (2019-2024)
Table 38. Europe Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 40. Europe Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Psychedelic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Psychedelic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Psychedelic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Psychedelic Drugs
Table 49. Key Market Challenges & Risks of Psychedelic Drugs
Table 50. Key Industry Trends of Psychedelic Drugs
Table 51. Global Psychedelic Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Psychedelic Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Psychedelic Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Psychedelic Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. COMPASS Pathways PLC Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 56. COMPASS Pathways PLC Psychedelic Drugs Product Offered
Table 57. COMPASS Pathways PLC Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. COMPASS Pathways PLC Main Business
Table 59. COMPASS Pathways PLC Latest Developments
Table 60. Pfizer Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 61. Pfizer Psychedelic Drugs Product Offered
Table 62. Pfizer Main Business
Table 63. Pfizer Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Pfizer Latest Developments
Table 65. Eli Lilly Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 66. Eli Lilly Psychedelic Drugs Product Offered
Table 67. Eli Lilly Main Business
Table 68. Eli Lilly Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Eli Lilly Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 71. GlaxoSmithKline Psychedelic Drugs Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Cybin Inc Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 76. Cybin Inc Psychedelic Drugs Product Offered
Table 77. Cybin Inc Main Business
Table 78. Cybin Inc Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Cybin Inc Latest Developments
Table 80. Field Trip Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 81. Field Trip Health Psychedelic Drugs Product Offered
Table 82. Field Trip Health Main Business
Table 83. Field Trip Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Field Trip Health Latest Developments
Table 85. ATAI Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 86. ATAI Life Sciences Psychedelic Drugs Product Offered
Table 87. ATAI Life Sciences Main Business
Table 88. ATAI Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. ATAI Life Sciences Latest Developments
Table 90. NUMINUS WELLNESS Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 91. NUMINUS WELLNESS Psychedelic Drugs Product Offered
Table 92. NUMINUS WELLNESS Main Business
Table 93. NUMINUS WELLNESS Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. NUMINUS WELLNESS Latest Developments
Table 95. MindMed Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 96. MindMed Psychedelic Drugs Product Offered
Table 97. MindMed Main Business
Table 98. MindMed Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. MindMed Latest Developments
Table 100. HAVN Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 101. HAVN Life Sciences Psychedelic Drugs Product Offered
Table 102. HAVN Life Sciences Main Business
Table 103. HAVN Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. HAVN Life Sciences Latest Developments
Table 105. Seelos Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 106. Seelos Therapeutics Psychedelic Drugs Product Offered
Table 107. Seelos Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Seelos Therapeutics Main Business
Table 109. Seelos Therapeutics Latest Developments
Table 110. Jannsen Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 111. Jannsen Psychedelic Drugs Product Offered
Table 112. Jannsen Main Business
Table 113. Jannsen Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Jannsen Latest Developments
Table 115. Acadia Pharmaceuticals Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 116. Acadia Pharmaceuticals Psychedelic Drugs Product Offered
Table 117. Acadia Pharmaceuticals Main Business
Table 118. Acadia Pharmaceuticals Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Acadia Pharmaceuticals Latest Developments
Table 120. Intellipharmaceutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 121. Intellipharmaceutics Psychedelic Drugs Product Offered
Table 122. Intellipharmaceutics Main Business
Table 123. Intellipharmaceutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Intellipharmaceutics Latest Developments
Table 125. Revive Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 126. Revive Therapeutics Psychedelic Drugs Product Offered
Table 127. Revive Therapeutics Main Business
Table 128. Revive Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Revive Therapeutics Latest Developments
Table 130. Mydecine Innovations Group Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 131. Mydecine Innovations Group Psychedelic Drugs Product Offered
Table 132. Mydecine Innovations Group Main Business
Table 133. Mydecine Innovations Group Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Mydecine Innovations Group Latest Developments
Table 135. Red Light Holland Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 136. Red Light Holland Psychedelic Drugs Product Offered
Table 137. Red Light Holland Main Business
Table 138. Red Light Holland Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Red Light Holland Latest Developments
Table 140. Braxia Scientific Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 141. Braxia Scientific Psychedelic Drugs Product Offered
Table 142. Braxia Scientific Main Business
Table 143. Braxia Scientific Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Braxia Scientific Latest Developments
Table 145. Mind Cure Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 146. Mind Cure Health Psychedelic Drugs Product Offered
Table 147. Mind Cure Health Main Business
Table 148. Mind Cure Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Mind Cure Health Latest Developments
Table 150. Entheon Biomedical Details, Company Type, Psychedelic Drugs Area Served and Its Competitors
Table 151. Entheon Biomedical Psychedelic Drugs Product Offered
Table 152. Entheon Biomedical Main Business
Table 153. Entheon Biomedical Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Entheon Biomedical Latest Developments
LIST OF FIGURES
Figure 1. Psychedelic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychedelic Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Psychedelic Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Psychedelic Drugs Sales Market Share by Country/Region (2023)
Figure 8. Psychedelic Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Psychedelic Drugs Market Size Market Share by Type in 2023
Figure 10. Psychedelic Drugs in Depressive Disorders
Figure 11. Global Psychedelic Drugs Market: Depressive Disorders (2019-2024) & ($ Millions)
Figure 12. Psychedelic Drugs in Post-Traumatic Stress Disorders
Figure 13. Global Psychedelic Drugs Market: Post-Traumatic Stress Disorders (2019-2024) & ($ Millions)
Figure 14. Psychedelic Drugs in Substance Abuse Disorders
Figure 15. Global Psychedelic Drugs Market: Substance Abuse Disorders (2019-2024) & ($ Millions)
Figure 16. Psychedelic Drugs in Obsessive Compulsive Disorders
Figure 17. Global Psychedelic Drugs Market: Obsessive Compulsive Disorders (2019-2024) & ($ Millions)
Figure 18. Psychedelic Drugs in Others
Figure 19. Global Psychedelic Drugs Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Psychedelic Drugs Market Size Market Share by Application in 2023
Figure 21. Global Psychedelic Drugs Revenue Market Share by Player in 2023
Figure 22. Global Psychedelic Drugs Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 24. APAC Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 25. Europe Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 27. Americas Psychedelic Drugs Value Market Share by Country in 2023
Figure 28. United States Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Psychedelic Drugs Market Size Market Share by Region in 2023
Figure 33. APAC Psychedelic Drugs Market Size Market Share by Type in 2023
Figure 34. APAC Psychedelic Drugs Market Size Market Share by Application in 2023
Figure 35. China Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Psychedelic Drugs Market Size Market Share by Country in 2023
Figure 42. Europe Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Figure 43. Europe Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Figure 44. Germany Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 58. APAC Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Europe Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 61. United States Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Canada Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 65. China Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Japan Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Korea Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 69. India Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Australia Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Germany Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 72. France Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 73. UK Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 74. Italy Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Russia Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Spain Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 79. Israel Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 82. Global Psychedelic Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Psychedelic Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Psychedelic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychedelic Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Psychedelic Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Psychedelic Drugs Sales Market Share by Country/Region (2023)
Figure 8. Psychedelic Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Psychedelic Drugs Market Size Market Share by Type in 2023
Figure 10. Psychedelic Drugs in Depressive Disorders
Figure 11. Global Psychedelic Drugs Market: Depressive Disorders (2019-2024) & ($ Millions)
Figure 12. Psychedelic Drugs in Post-Traumatic Stress Disorders
Figure 13. Global Psychedelic Drugs Market: Post-Traumatic Stress Disorders (2019-2024) & ($ Millions)
Figure 14. Psychedelic Drugs in Substance Abuse Disorders
Figure 15. Global Psychedelic Drugs Market: Substance Abuse Disorders (2019-2024) & ($ Millions)
Figure 16. Psychedelic Drugs in Obsessive Compulsive Disorders
Figure 17. Global Psychedelic Drugs Market: Obsessive Compulsive Disorders (2019-2024) & ($ Millions)
Figure 18. Psychedelic Drugs in Others
Figure 19. Global Psychedelic Drugs Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Psychedelic Drugs Market Size Market Share by Application in 2023
Figure 21. Global Psychedelic Drugs Revenue Market Share by Player in 2023
Figure 22. Global Psychedelic Drugs Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 24. APAC Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 25. Europe Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Psychedelic Drugs Market Size 2019-2024 ($ Millions)
Figure 27. Americas Psychedelic Drugs Value Market Share by Country in 2023
Figure 28. United States Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Psychedelic Drugs Market Size Market Share by Region in 2023
Figure 33. APAC Psychedelic Drugs Market Size Market Share by Type in 2023
Figure 34. APAC Psychedelic Drugs Market Size Market Share by Application in 2023
Figure 35. China Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Psychedelic Drugs Market Size Market Share by Country in 2023
Figure 42. Europe Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Figure 43. Europe Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Figure 44. Germany Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Psychedelic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 58. APAC Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Europe Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 61. United States Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Canada Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 65. China Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Japan Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Korea Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 69. India Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Australia Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Germany Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 72. France Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 73. UK Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 74. Italy Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Russia Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Spain Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 79. Israel Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Psychedelic Drugs Market Size 2025-2030 ($ Millions)
Figure 82. Global Psychedelic Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Psychedelic Drugs Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Laminar Flow Storage Cabinets Market Growth 2023-2029
US$ 3,660.00
March 2023
92 pages
Global Medicine Display Cabinet Market Growth 2023-2029
US$ 3,660.00
March 2023
103 pages
Global Healthcare Information Technology (HIT) Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
153 pages
Global Abdominal Aortic Aneurysm Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
112 pages
